1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Medulloblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barthomeuf, C; Béliveau, R; Blanchette, M; Boivin, D; Gingras, D; Lamy, S | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Medulloblastoma
| Article | Year |
|---|---|
Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis.
Topics: Animals; Aorta; Cattle; Cell Movement; Cells, Cultured; Chemotaxis; Endothelium, Vascular; Fibrosarcoma; Flavonoids; Glioblastoma; Humans; Lysophospholipids; Medulloblastoma; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Neovascularization, Physiologic; p38 Mitogen-Activated Protein Kinases; Phenols; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Polyphenols; Receptors, G-Protein-Coupled; Sphingosine; Vascular Endothelial Growth Factor A; Vitis | 2006 |